• Home
  • Magazine
    • Current Issue
    • Past Issues
    • Subscribe/Renew
    • Change Mailing Address
    • Cancel Subscription
    • Digital Editions
    • Article Reprints
    • List Rentals
    • Email Newsletter Subscription
  • Resource Centers
    • Biopharm Dev & Mfg
    • Clinical Trials
    • Contract Drug Dev & Mfg
    • CRO
    • Pharma Dev & Mfg
    • R&D
    • Regulatory Compliance
    • Supply Chain/Cold Chain
    • Industry Events
  • Advertising
    • Advertising Contacts
    • Ad Specifications
    • Our Audience
    • High-Impact Advertising
    • Media Kit Request
  • Editorial
    • Editorial Calendar
    • Editorial Guidelines
    • Editorial Contacts
    • Editorial Philosophy
    • Something Extra
  • Blogs
    • Chief Editor Rob Wright
    • Contributing Editors
  • Media
    • Podcasts
    • Videos
  • About Us
    • About Life Science Leader
    • Contact Us
Home Magazine Past Issues 2011 - September

2011 - September

Children categories

From The Editor

View items...

Ask The Board

View items...

Outsourcing Insights

View items...

Bio Data Points

View items...

Feature

View items...

Pharma Manufacturing

View items...

Biopharm Development & Manufacturing

View items...

Finance & Business Development

View items...

Industry Leader

View items...

Leadership Lessons

View items...

2011 - September

From The Editor

Old Dog – New Tricks

Ask The Board

Ask The Board

Outsourcing Insights

Benefit From Clinical Trials In Emerging Markets While Limiting Risk Exposure

Bio Data Points

Can Outsourcing GMP Operations To China Really Work?

Feature

Massachusetts Life Sciences Center: A Beacon To Academia And Industry
AvidBiotics: Punching Holes In Bacterial Resistance
A New Paradigm For Strategic Partnerships
Above The Line Of High Risk

Pharma Manufacturing

Advances In Aseptic BFS Processing Of Pharma Liquids Improve Product Integrity And Patient Safety
Stickpack Packaging: Increasing Product Safety, Convenience, And Cost-Savings

Biopharm Development & Manufacturing

Biobetters Q&A
New Study Finds Biotechs Cut R&D Spending While Still Securing Financing

Finance & Business Development

Social Media And Pharma – An Untapped Value Proposition For The Life Sciences Industry

Industry Leader

505(b)(2): Fast Development, Cost-Effective Approach For Small Or Large Molecule
Better Tools For Predicting The Future

Leadership Lessons

A Question Of Context
Copyright VertMarkets 2012
Scroll To Top